Prizor Viztech (PRIZOR)
Fast GrowerScore breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹182.2 |
| Market Cap | ₹194.79 Cr |
| P/E Ratio | 31.28 |
| ROCE | 45.27% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 38.08% |
| Debt/Equity | — |
| Sales Growth | 35.39% |
| Promoter Holding | 67.93% |
| 52-Week Range | ₹216.65 — ₹1,248.85 |
| Sector | Industrial Manufacturing |
Strengths
- ROCE of 45.27% indicates strong capital efficiency
- Sales and profit growth of 35.39% and 38.08% show solid momentum
- Piotroski F-Score of 7/9 suggests healthy fundamentals
- Promoter holding of 67.93% aligns owner interests
- PEG of 0.85 implies growth is reasonably valued relative to P/E
Concerns
- P/E of 31.28 leaves a thin margin of safety
- No dividend yield provides no income while waiting
- Book value, ROE, and debt/equity are undisclosed, limiting risk assessment
- Sharp fall from 52-week high of ₹939.20 to ₹565 highlights volatility
- Small market cap of ₹368 Cr may mean limited liquidity
AI Analysis
At ₹565, Prizor Viztech carries a market cap of ₹368 Cr and a P/E of 31.28. I am not a buyer of growth at any price, so I must ask what quality this price buys. The first thing that stands out is ROCE of 45.27% — a figure that would make many businesses blush. Pair that with sales growth of 35.39% and profit growth of 38.08%, and you have a small industrial-products company compounding at an impressive clip. The Piotroski F-Score of 7/9 also suggests healthy fundamentals, not accounting fiction. Promoters hold 67.93%, aligning their interests with mine. The PEG ratio of 0.85 hints that growth is not fully overpaid for, despite the absolute P/E. But Graham would demand a margin of safety. A 31 P/E leaves little room for error. There is no dividend to compensate while waiting, and with book value, ROE, and debt/equity undisclosed, I cannot assess the balance sheet risk or the true return on equity. The 52-week range — from ₹216.65 to ₹939.20, now ₹565 — tells me this is a volatile stock, not a stable compounder. Latest quarter sales of ₹42 Cr and net profit of ₹6 Cr imply a net margin near 14%, respectable, but one quarter does not make a franchise. I need to see whether this growth persists, whether the company can fund it without excessive leverage, and whether management will eventually share profits with shareholders. For now, it is an interesting fast grower, but I would not let the high ROCE seduce me into abandoning valuation discipline. I would watch from the sidelines until more data and a better price appear.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer